ARV-471: an Oral ER Degrader for ER+/HER2- Breast Cancer
Arvinas ER Chimeric Degrader
CRBN-based heterobifunctional ER degrader oral Ph. II candidate for ER+/HER2- BC from ER ligand and CRBN ligand ARV-471 Arvinas, New Haven, CT
Loading...
CRBN-based heterobifunctional ER degrader oral Ph. II candidate for ER+/HER2- BC from ER ligand and CRBN ligand ARV-471 Arvinas, New Haven, CT